Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating analgesia for hip arthroplasty using liposomal bupivacaine in combination with either standard bupivacaine or ropivacaine for the PENG …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Exparel (liposomal bupivacaine) (liposomal bupivacaine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Femoral Neck Fractures, Femur Head Necrosis | Phase 4 | Status: RECRUITING